With its latest $110 million financing, Moderna Therapeutics Inc. is rapidly closing on the half-billion-dollar mark in terms of funds raised for the 2-year-old company. The new funds bring the company’s total funds raised to $415 million, and it will end the year with about $340 million in the bank.